Reply to PIL seeking direct access to COVID-19 drugs, HC tells govt.
The HinduThe Bombay High Court on Friday directed the Maharashtra government to reply to a plea seeking that medicines used to treat COVID-19 patients be made available directly at hospitals, isolation and quarantine centres where such patients are being admitted. The PIL claimed that since medicines which are crucial for treating COVID-19, such as Remdesivir, and an injection Actemra, are available only at select chemists, a patient loses much time in buying the drugs and availing themselves of treatment. If the drugs were instead made available at COVID-19 treatment facilities, much time would be saved and immediate care can be given to the patients through doctors and the hospital staff.” Mr. Pandey also said people are being made to pay exorbitant prices for medicines such as Remdesivir. The PIL sought a direction from the court to the State government to make such medicines, including Remdesivir 100, Actemra 400 injections and FabiFlu tablets, available at all government and private hospitals treating COVID-19 patients, and at medical stores.